MINIMALLY INVASIVE SURGERY MARKET ANALYSIS

Global minimally invasive surgery market is estimated to be valued at US$ 72,554.0 million in 2023, exhibiting a CAGR of 11.0% during the forecast period (2023-2030).

Analysts’ Views on Global Minimally Invasive Surgery Market:

Usage of minimally invasive surgery for the treatment of major chronic diseases is expected to drive the global minimally invasive surgery market growth over the forecast period. For instance, in October 2021, according to data published by Mayo Foundation for Medical Education and Research, a nonprofit academic medical center that focuses on integrated health care, education, and research, stated that minimally invasive heart surgery can reduce aortic stenosis symptoms and improve quality of life of cardiac patients.

Figure 1. Global Minimally Invasive Surgery Market Share (%), By Device Type, 2023

To learn more about this report, request a free sample copy

Global Minimally Invasive Surgery Market – Drivers

Increasing Prevalence of Orthopedic Diseases 

Increasing prevalence of orthopedic diseases is expected to drive the global minimally invasive surgery market growth over the forecast period. For instance, in July 2022, according to World Health Organization (WHO), approximately 1.71 billion people have musculoskeletal conditions worldwide.

Figure 2. Global Minimally Invasive Surgery Market Value (US$ Million), By Region, 2023

To learn more about this report, request a free sample copy

Global Minimally Invasive Surgery Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global minimally invasive surgery market over the forecast period. North America holds 43.2% market share, owing to increasing prevalence of cardiac diseases in this region. For instance, in August 2022, according to an article published by New York State Department of Health, about 697,000 people dies due to cardiac disease in the U.S. every year.

Global Minimally Invasive Surgery Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global minimally invasive surgery market growth as the hospitals needed to sort the urgency of their daily surgical procedures. For instance, according to an article published  by PubMed Central, in July 2020, a survey was conducted and it was found that the all hospitals had to think about non-surgical options whenever they could due to the urgency of their daily surgical treatments.

Global Minimally Invasive Surgery Market- Segmentation

Global minimally invasive surgery market report is segmented into device type, surgery, and region

Based on Device Type, the market is segmented into surgical devices (ablation devices, electrosurgical devices, and medical robotic systems), monitoring & visualization devices, and endoscopy devices).  Out of which, the surgical devices segment is expected to hold a dominant position in the global minimally invasive surgery market during the forecast period, owing to increasing usage of endoscopy devices in minimally invasive surgery procedures.

Based on Surgery, the market is segmented into orthopedic surgery, cosmetic surgery, breast surgery, vascular surgery, thoracic surgery, gynecological surgery, bariatric surgery, cardiac surgery, gastrointestinal surgery, and urological surgery. Out of which, the cardiac surgery segment is expected to hold a dominant position in the global minimally invasive surgery market during the forecast period , owing to increasing prevalence of cardiac disorders.

Among all segmentation, the surgery segment has the highest potential to drive the market growth due to increasing prevalence of orthopedic surgery over the forecast period. For instance, in December 2021, according to the World Health Organization, about 28.2% of the global population of age 60 years and older sufferes from osteoarthritis.

Global Minimally Invasive Surgery Market- Cross Sectional Analysis

In surgery, cardiac surgery held a dominant segment in North America region due to increasing prevalence of cardiac disorders. For instance, in July 2020, according to Healthline Media LLC, a consumer health publisher, about 647,000 people die due to cardiac disease every year that makes it the leading cause of death in the U.S.

Global Minimally Invasive Surgery Market- Key Developments

• Effective usage of minimally invasive surgery software to treat different diseases is expected to drive the market growth over the forecast period. For instance, in January 2020, according to an article published by JAMA Network, a monthly open access medical journal, in a cohort study of 169 404 patients in 73 hospitals, the usage of robotic surgery for all general surgery procedures has increased from 1.8% to 15.1% from 2012 to 2018.
• In December 2022, Abbott, a global healthcare company, announced the launch of its latest-generation transcatheter aortic valve implantation (TAVI) systemnamed Navitor, and thus, made minimally invasive device available to people in India with severe aortic stenosis who are at high or extreme surgical risk.
• In December 2021, Integer Holdings Corporation, a leading medical device outsource (MDO) manufacturer, announced the acquisition of Oscor, Inc., a privately-held company that designs, develops, manufactures, and markets a comprehensive portfolio of highly specialized medical devices, venous access systems, and diagnostic catheters, and implantable devices, to develop more devices useful in minimally invasive surgery.
• In August 2021, Zimmer Biomet, a global medical technology leader, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its ROSA Hip System for robotically-assisted direct anterior total hip replacement.

Global Minimally Invasive Surgery Market: Key Trends

Increasing Number of Cardiac Surgeries

Increasing number of cardiac surgeries is expected to drive the global minimally invasive surgery market growth over the forecast period. For instance, in June 2022, according to an article published by National Institute of Health, more than 2 million people  underwent open-heart surgery to treat various heart problems worldwide, every year.

Global Minimally Invasive Surgery Market: Restraint

Disadvantages Associated with Minimally Invasive Surgery

Global minimally invasive surgery market growth can be hindered by disadvantages associated with minimally invasive surgery. For instance, in October 2020, according to Spine Institute of North America, a leading spine and pain specialist, the main disadvantage of minimally invasive surgery is that it requires a higher level of training, and thus, insufficient training can lead to complications such as perforation of the gallbladder, biliary leak, bile duct injury, biliary stricture, etc.

Hence, reducing the disadvantages associated with minimally invasive surgery will assess in the growth of the global minimally invasive surgery market.

Global Minimally Invasive Surgery Market - Key Players

Major players operating in the global minimally invasive surgery market include Abbott, ArthroCare Corporation, Integer Holdings Corporation, Zimmer Biomet, DePuy Synthes, Inc., Conmed Corporation, GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., Biom’up SA, and Integrated Endoscopy

*Definition: Minimally invasive surgery allows surgeon to use techniques that limit the size and number of cuts, or incisions. It is considered safe as compared to open surgery. The patient usually recover more quickly, spend less time in the hospital, and feel more comfortable while healing.